Brancucci, Nicolas M. B. https://orcid.org/0000-0003-0655-3266
Gumpp, Christin
van Gemert, Geert-Jan
Yu, Xiao
Passecker, Armin
Nardella, Flore
Thommen, Basil T. https://orcid.org/0000-0001-7655-2440
Chambon, Marc
Turcatti, Gerardo https://orcid.org/0000-0003-0139-223X
Halby, Ludovic
Blasco, Benjamin
Duffey, Maëlle https://orcid.org/0000-0002-4319-0647
Arimondo, Paola B.
Bousema, Teun https://orcid.org/0000-0003-2666-094X
Scherf, Artur https://orcid.org/0000-0003-2411-3328
Leroy, Didier https://orcid.org/0000-0002-5594-3204
Kooij, Taco W. A. https://orcid.org/0000-0002-8547-7523
Rottmann, Matthias https://orcid.org/0000-0002-2207-7899
Voss, Till S. https://orcid.org/0000-0002-1464-4988
Article History
Received: 4 December 2024
Accepted: 8 July 2025
First Online: 25 July 2025
Competing interests
: D.L. is an employee of Medicines for Malaria Venture (MMV). B.B. and M.D. are employees of the Global Antibiotic Research & Development Partnership (GARDP) and were employed at MMV at the time of conceptualization and execution of the work. The remaining authors declare no competing interests.